Description
Specifications
| Form | Lyophilized powder, single vial |
| Contents | Tesamorelin 10 mg · Ipamorelin 5 mg |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| Tesamorelin | C₂₂₁H₃₆₆N₇₂O₆₇S · MW 5135.9 · CAS 218949-48-5 |
| Ipamorelin | C₃₈H₄₉N₉O₅ · MW 711.9 · CAS 170851-70-4 |
How Is This Blend Studied?
This blend pairs a stabilized GHRH analog with a selective ghrelin (GHS) receptor agonist. Tesamorelin is studied for GHRH receptor activation on pituitary somatotrophs, and Ipamorelin for selective GHS-R signaling. Together they are used in preclinical models of complementary GHRH and ghrelin-receptor pathway activation.
Storage
Store the sealed vial at −20 °C long-term or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and avoid repeated freeze-thaw cycles. See our storage guide.
FAQ
Is Tesamorelin available on its own?
Yes. See Tesamorelin. For a GHRH(1-29) pairing, see the Ipamorelin / CJC-1295 blend.
Is a Certificate of Analysis available?
Yes. Tap “View Certificate of Analysis” on this page for the current lot’s third-party COA.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
